-
Media Room Article
Cancer Research Institute Names 26 New Postdoctoral Fellows
New York, NY – The Cancer Research Institute (CRI) is pleased to announce the Winter 2025 Class… -
Media Room Article
CRI Launches Pioneering Phase 2/3 Trial Using Labcorp Liquid Biopsy to Guide Precision Immunotherapy for Lung Cancer
NEW YORK, NY – The Cancer Research Institute (CRI) is pleased to announce the enrollment of the… -
Media Room Article
First Patient Enrolled in New Sub-study in Ovarian Cancer Immunotherapy Platform Trial
Expansion of the IPROC platform study introduces a new immunotherapy combination and patient population, accelerating progress toward… -
Media Room Article
Quilceda Creek to Release Rare Library Wines in Support of Cancer Research Institute, Funding Lifesaving Immunotherapy Research
Prestigious Cabernet producer aims to raise $250,000 for groundbreaking cancer research through limited October release SNOHOMISH, Wash.,… -
Media Room Article
Cancer Research Institute Introduces IGNITE Award to Propel Next Generation of Cancer Immunotherapy Leaders with Five Years of Support
New York, NY — The Cancer Research Institute (CRI) today announced the launch of its IGNITE Award—Inspiring… -
Media Room Article
Cancer Research Institute Names 25 New Postdoctoral Fellows, Fulfilling $2.5M Commitment Amid NIH Disruptions
New York, NY — The Cancer Research Institute (CRI) announced today the Spring 2025 Class of CRI… -
Media Room Article
Cancer Research Institute and Mount Sinai Team Up to Improve Patient Outcomes in Immunotherapy
New York, NY — In a new collaboration that could transform how cancer is treated, the Cancer Research… -
Media Room Article
CRI Announces 2025 Lloyd J. Old STARs: Five Bold Innovators Driving the Future of Cancer Immunotherapy
New York, NY — The Cancer Research Institute (CRI) proudly announces the 2025 class of Lloyd J…. -
Media Room Article
Cancer Research Institute Publishes Inaugural 2025 Cancer Immunotherapy Insights + Impact Report
New York, NY — The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing immune-based treatments…
